Insulin for type 2 diabetes: Choosing a second-line insulin regimen

International Journal of Clinical Practice

Volumn 62, Issue 11, 2008, Pages 1647-1653

  Barnett, A ^a,g   Begg, A ^b   Dyson, P ^c   Feher, M ^d   Hamilton, S ^e   Munro, N ^d,f  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Links Health Centre   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e QUEEN MARY S HOSPITAL   (United Kingdom)

^f Little Orchard   (United Kingdom)

^g BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; INSUMAN BASAL; INSUMAN RAPID; ISOPHANE INSULIN; NEUTRAL INSULIN; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

CLINICAL DECISION MAKING; CLINICAL PRACTICE; CONFERENCE PAPER; CONSENSUS; DIABETIC PATIENT; EXERCISE; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; LIFESTYLE; MEDICAL EXPERT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ALGORITHMS; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DIET; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LIFE STYLE; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; WEIGHT GAIN;

EID: 54049145900     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01909.x     Document Type: Conference Paper

References (16)

1. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. J Am Med Assoc 1999 281 : 2005 12.
2. Rubino A, McQuay LJ, Gough SC et al. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK. Diabet Med 2007 24 : 1412 8.
3. Calvert MJ, McManus RJ, Freemantle N. Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study. Br J Gen Pract 2007 57 : 455 60.
4. National Institute for Health and Clinical Excellence. Type 2 Diabetes. http://www.nice.org.uk/nicemedia/pdf/CG66NICEGuidance.pdf (accessed May 2008).
5. Holman RR, Thorne KI, Farmer AJ et al. Addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 2007 357 : 1716 30.
6. Department of Health Quality Outcomes Framework. Guidance, Updated August 2004. http://www.dh.gov.uk/en/Healthcare/Primarycare/Primarycarecontracting/QOF (accessed June 2008).
7. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 2003 26 : 881 5.
8. Bretzel RG, Nuber U, Landgraf W et al. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. Lancet 2008 371 : 1073 84.
9. Rosenstock J, Davies M, Home PD et al. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia 2008 51 : 408 16.
10. Barratt R, Frost G, Millward DJ, Truby H. A randomised controlled trial investigating the effect of an intensive lifestyle intervention vs. standard care in adults with type 2 diabetes immediately after initiating insulin therapy. Br J Nutr 2008 99 : 1025 31.
11. Aas AM, Bergstad I, Thorsby PM et al. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study. Diabet Med 2005 22 : 316 22.
12. Yki-Järvinen H, Kauppinen-Mäkelin R, Tiikkainen M et al. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia 2006 49 : 442 51.
13. Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999 46 : 239 46.
14. O'Kane M, Bunting B, Copeland M, Coates VE. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. Br Med J 2008 336 : 1174 7.
15. Simon J, Gray A, Clarke P et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. Br Med J 2008 336 : 1177 80.
16. International Diabetes Federation. Guideline for Management of Postmeal Glucose, 2007. http://www.idf.org/webdata/docs/Guideline_PMG_final.pdf (accessed May 2008).